IBD Archives -

Digital-therapeutics-grow-up-1200x675-Feature

As demonstrated throughout COVID, digital health is no longer experimental. Digital technologies are proving their value by allowing

How digital pathways are changing healthcare

https://pharmaphorum.com/digital/how-digital-pathways-are-changing-healthcare/

Events/ Events/ Patients

PREDiCT: Autoimmune Disease Modeling Summit

jenna.warren@hansonwade.com autoimmune, Diabetes, IBD, lupus, Sclerosis 0 Comment

Deploy Advanced Models to Enhance Your Confidence & Und

PREDiCT: Autoimmune Disease Modeling Summit

https://pharmaphorum.com/events/predict-autoimmune-disease-modeling-summit/

Market Access/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis

Celltrion gears up for subcutaneous infliximab launch in Europe

Richard Staines biosimilars, Celltrion, IBD, infliximab, Rheumatoid arthritis 0 Comment

Celltrion Healthcare’s subcutaneous (SC) formulation of its infliximab biosimilar, codenamed CT-P13 SC, looks set to launch in Europe

Celltrion gears up for subcutaneous infliximab launch in Europe

https://pharmaphorum.com/views-analysis-market-access/celltrion-gears-up-for-subcutaneous-infliximab-launch-in-europe/

News/ News/ R&D

Takeda proposes selling Shire’s IBD treatment after merger

Joy Persaud IBD, Shire, Takeda 0 Comment

Takeda has proposed selling off a Shire treatment for inflammatory bowel disease when the companies merge next year,

Takeda proposes selling Shire’s IBD treatment after merger

https://pharmaphorum.com/news/takeda-proposes-selling-shires-ibd-treatment-after-merger/

Market Access/ News/ News

FDA approves oral treatment for ulcerative colitis

Linda Banks colon disease, IBD, inflammatory bowel disease, JAK inhibitor, Pfizer, ulcerative colitis, Xeljanz 0 Comment

Pfizer’s janus kinase (JAK) inhibitor drug Xeljanz (tofacitinib) has received expanded approval from the FDA for adults with moderately-to-severely-active ulcerative colitis.

FDA approves oral treatment for ulcerative colitis

https://pharmaphorum.com/news/fda-oral-treatment-ulcerative-colitis/

Trending

IBD

Login